PMC:7029759 / 24738-25054
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 556 | 16-20 | Gene | denotes | ACE2 | Gene:59272 |
| 557 | 94-98 | Gene | denotes | ACE2 | Gene:59272 |
| 558 | 166-170 | Gene | denotes | ACE2 | Gene:59272 |
| 569 | 43-51 | Species | denotes | patients | Tax:9606 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T599 | 16-20 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T598 | 94-98 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T597 | 140-154 | GO:0019814 | denotes | immunoglobulin |
| T596 | 158-164 | SO:0000417 | denotes | domain |
| T595 | 166-170 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T594 | 198-206 | UBERON:0000104 | denotes | lifespan |
| T593 | 226-234 | CHEBI:36357;CHEBI:36357 | denotes | molecule |
| T592 | 258-266 | CHEBI:35224;CHEBI:35224 | denotes | effector |
| T591 | 284-297 | UBERON:0002405 | denotes | immune system |
| T590 | 310-315 | NCBITaxon:10239 | denotes | virus |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T150 | 140-154 | Body_part | denotes | immunoglobulin | http://purl.org/sig/ont/fma/fma62871 |
| T151 | 284-297 | Body_part | denotes | immune system | http://purl.org/sig/ont/fma/fma9825 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T16 | 284-297 | Body_part | denotes | immune system | http://purl.obolibrary.org/obo/UBERON_0002405 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T221 | 24-25 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T222 | 155-157 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T223 | 171-173 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T224 | 284-297 | http://purl.obolibrary.org/obo/UBERON_0002405 | denotes | immune system |
| T225 | 310-315 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T89 | 226-234 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
| T90 | 258-266 | Chemical | denotes | effector | http://purl.obolibrary.org/obo/CHEBI_35224 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T160 | 0-316 | Sentence | denotes | In order to use ACE2 as a therapy to treat patients, it would be advisable to convert soluble ACE2 into an immunoadhesin format fused to an immunoglobulin Fc domain (ACE2-Fc), thereby extending the lifespan of the circulating molecule, while also recruiting effector functions of the immune system against the virus. |